Medication info
Teneligliptin MS Extended Release 20/1000 mg

Teneligliptin MS Extended Release 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
Pink oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201326 · Approved 2022.04.04 · Insurance code 647304280

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes

View approved original text

This medication helps control blood glucose in patients with type 2 diabetes by using Teneligliptin and Metformin together. It is effective in improving blood glucose levels in conjunction with dietary and exercise regimens. This supports patients in managing their blood glucose levels more reliably. Such treatment plays a vital role in diabetes management, hence regular use is necessary. As a result, this medication is used to enhance blood glucose control in type 2 diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for the treatment of diabetes and is a combination of two components. First, this medication should not be administered to patients with reduced kidney function, especially in cases where kidney function is moderately impaired or worse. Second, it should also be avoided in patients with severely reduced heart function or those with acute heart disease or severe infections. Third, patients who are scheduled to undergo tests using iodine-based radiocontrast agents should discontinue the medication 48 hours prior to the test and should only resume after confirming normal kidney function post-test. Fourth, women who are pregnant or may become pregnant should not take this medication. Fifth, this medication may cause hypoglycemia; therefore, caution should be exercised for symptoms of hypoglycemia, especially when taken with insulin or sulfonylurea medications. Sixth, if severe abdominal pain, vomiting, constipation, breathing difficulties, fever, skin rash, or other abnormal symptoms occur during treatment, immediate medical consultation is required. Seventh, patients with liver dysfunction or those who excessively consume alcohol should avoid this medication, and if signs of liver dysfunction are present, the medication should be discontinued. Eighth, elderly patients may have reduced kidney function, so regular kidney function tests should be conducted, and dosing should be adjusted accordingly. Ninth, this medication can lower vitamin B12 levels; hence, patients taking this medication over long periods are recommended to have regular blood tests to monitor vitamin B12 status. Finally, this medication has not established safety and efficacy in children, so it is advisable not to use it.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
Show 153 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colon polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • reduced appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • latent hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • increased serum potassium levels
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • myasthenia
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • cold sweat
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • blood glucose abnormalities
  • increased blood glucose
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral stones
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue inflammation
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory anomalies
  • insomnia
  • urticaria
  • hepatic coma
  • sensory impairment
  • decreased sensation
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • postural dizziness
  • muscle weakness
  • back pain
  • limb pain
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle spasms
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • postmenopausal osteoporosis
  • chronic bronchitis
  • turbinate hypertrophy
  • hypercholesterolemia
  • hyperlipidemia
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • sputum abnormalities
  • dyspnea
  • acute respiratory distress
  • atelectasis
  • nasal bleeding
  • chest discomfort
  • fever
  • chills
  • generalized edema
  • injection site inflammation
  • ovarian cyst
  • vulvar pruritus
  • menopause symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip injury
  • contusion
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • angina
  • ear pain
  • iron deficiency anemia
  • food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is safest when stored at room temperature between 1°C and 30°C. Therefore, it is advisable to avoid direct sunlight or high temperatures, and not to place it in excessively cold or hot locations.

Appearance and packaging

Appearance

Pink oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.